OR WAIT null SECS
April 19, 2018
Johnson & Johnson’s Janssen partners with Bristol-Myers Squibb to advance next-generation therapies for cardiovascular diseases.
April 09, 2018
The acquisition is expected to accelerate progress towards personalized cancer healthcare.
Roche has acquired a program to develop regenerative therapies for multiple sclerosis.
Under this global collaboration, the companies will develop encapsulated cell therapies for treating Type 1 diabetes.
April 06, 2018
Boehringer Ingelheim and OSE Immunotherapeutics have entered a global immuno-oncology partnership to develop a checkpoint inhibitor for treating advanced solid tumors.
April 05, 2018
The companies have created Syna Therapeutics, a joint venture that will develop biosimilars and new molecules.
Fujifilm acquires cell culture media companies Irvine Scientific Sales Company and IS Japan.
April 03, 2018
Pfizer transfers CAR-T assets to Allogene Therapeutics under a new alliance to further develop immuno-oncology therapeutics.
April 02, 2018
New therapies and tighter budgets challenge bio/pharma to think outside the industry.
March 30, 2018
The company’s close communication with customers has enabled it to bring advanced pipetting products to market.